Skip to main content
Clinical Trials/NCT04681547
NCT04681547
Completed
Phase 4

Ultrasound-guided Genicular Nerve Block: An Analgesic Alternative to LIA for Total Knee Arthroplasty.

Hospital Clinic of Barcelona1 site in 1 country60 target enrollmentDecember 15, 2020
ConditionsPain

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Pain
Sponsor
Hospital Clinic of Barcelona
Enrollment
60
Locations
1
Primary Endpoint
NRS at PACU
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The hypothesis is to demonstrate the analgesic non-inferiority of the ultrasound-guided geniculate nerve block when compared to the local infiltration analgesia (LIA). It is expected to maintain the quality of analgesia with a selective blockade of the nerves responsible for the sensitive innervation of the knee, reducing the total dose of local anesthetic and adrenaline very markedly.

Detailed Description

The main objective is to demonstrate that the ultrasound-guided geniculate nerve block provides not-inferior analgesia to LIA in patients undergoing primary total knee arthroplasty (TKA) in the first 24 hours postoperatively, and during the first mobilization using the numerical evaluation of the pain (NRS). The secondary objectives are to demonstrate that the consumption of opioids and the range of joint mobility are not inferior in those patients who receive geniculate nerve blocks compared to those who receive LIA.

Registry
clinicaltrials.gov
Start Date
December 15, 2020
End Date
April 30, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

TOMAS MIGUEL CUÑAT LOPEZ

Principal Investigator

Hospital Clinic of Barcelona

Eligibility Criteria

Inclusion Criteria

  • Subjects scheduled for primary elective total knee arthroplasty
  • American Society of Anesthesiologists Physical Status I-III
  • BMI 18-40 kg/m2

Exclusion Criteria

  • Inability to cooperate with protocol
  • Allergy to any medication of protocol
  • Contraindication to peripheral nerve block (e.g. local or systemic infection, neurologic deficit or disorder, previous trauma or surgery to ipsilateral knee, etc.)
  • Revision or prothesis replacement knee surgery
  • Chronic opioid consumption (daily morphine equivalent of \>30 mg for at least four weeks prior to surgery)
  • Bleeding diathesis or non-pharmacological coagulopathy

Outcomes

Primary Outcomes

NRS at PACU

Time Frame: 1 hour after surgery

NRS \[Numerical Rating Scale, 0-11\] at PACU \[post-anaesthesia care unit\] after spinal block reversal, evaluated as active contralateral knee genuflection at 90 degrees.

NRS at 12 hours after surgery

Time Frame: 12 hours

Pain will be assessed by NRS \[Numerical Rating Scale, 0-11\] by a ward nurse, blind for intraoperative analgesic treatment.

NRS at 24 hours after surgery

Time Frame: 24 hours

Pain will be assessed by NRS \[Numerical Rating Scale, 0-11\] by a ward nurse, blind for intraoperative analgesic treatment.

NRS after physiotherapy

Time Frame: 24 hours

It corresponds to day 1 after the surgical intervention and will be carried out in the hospitalization room by a physiotherapist. The NRS \[Numerical Rating Scale, 0-11\] will be recorded during the first examination and mobilization

Secondary Outcomes

  • Opioid consumption in the postoperative period(until 24 hours)
  • Quality of sleep(24 hours)
  • Knee mobility range(24 hours)

Study Sites (1)

Loading locations...

Similar Trials